We are live on ! Find out more
ICVX

Icosavax, Inc. Common Stock

Delisted

ICVX was delisted on the 16th of February, 2024.

66 hedge funds and large institutions have $195M invested in Icosavax, Inc. Common Stock in 2023 Q1 according to their latest regulatory filings, with 12 funds opening new positions, 20 increasing their positions, 18 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

144% more call options, than puts

Call options by funds: $78K | Put options by funds: $32K

11% more repeat investments, than reductions

Existing positions increased: 20 | Existing positions reduced: 18

2% more funds holding

Funds holding: 6566 (+1)

9% more first-time investments, than exits

New positions opened: 12 | Existing positions closed: 11

0% more funds holding in top 10

Funds holding in top 10: 22 (0)

25% less capital invested

Capital invested by funds: $258M → $195M (-$63.3M)

Holders
66
Holders Change
+1
Holders Change %
+1.54%
% of All Funds
1.05%
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.03%
New
12
Increased
20
Reduced
18
Closed
11
Calls
$78K
Puts
$32K
Net Calls
+$46K
Net Calls Change
-$193K
Name Holding Trade Value Shares
Change
Change in
Stake
Fidelity Investments
1
Fidelity Investments
Massachusetts
$34.8M +$9.66M +1,117,631 +23%
RCM
2
RA Capital Management
Massachusetts
$34.6M
T. Rowe Price Investment Management
3
T. Rowe Price Investment Management
Maryland
$27.1M +$1.76M +203,860 +5%
QUSVM
4
Qiming U.S. Ventures Management
Washington
$20.4M
PIM
5
Platinum Investment Management
Australia
$14.2M +$1.73M +200,191 +9%
ASP
6
Adams Street Partners
Illinois
$12.9M -$2.2M -254,918 -10%
Citadel Advisors
7
Citadel Advisors
Florida
$9.09M -$24.4K -2,822 -0.2%
BlackRock
8
BlackRock
New York
$7.6M -$492K -56,929 -4%
Vanguard Group
9
Vanguard Group
Pennsylvania
$5.39M +$218K +25,213 +3%
RSCM
10
Rock Springs Capital Management
Maryland
$5.01M +$721K +83,510 +11%
LCM
11
Laurion Capital Management
New York
$4.31M
CAM
12
Cormorant Asset Management
Massachusetts
$3.73M
State Street
13
State Street
Massachusetts
$2.67M +$14.8K +1,718 +0.4%
Geode Capital Management
14
Geode Capital Management
Massachusetts
$2.43M +$276K +31,947 +8%
Citigroup
15
Citigroup
New York
$1.82M -$1.6K -185 -0.1%
Northern Trust
16
Northern Trust
Illinois
$999K -$71.4K -8,268 -5%
VCIM
17
Velan Capital Investment Management
Georgia
$870K +$1.3M +150,000 New
Two Sigma Investments
18
Two Sigma Investments
New York
$553K +$172K +19,910 +26%
Susquehanna International Group
19
Susquehanna International Group
Pennsylvania
$485K +$722K +83,536 New
Millennium Management
20
Millennium Management
New York
$432K +$643K +74,449 New
Jacobs Levy Equity Management
21
Jacobs Levy Equity Management
New Jersey
$405K -$586K -67,794 -49%
Bank of New York Mellon
22
Bank of New York Mellon
New York
$403K -$8.24K -954 -1%
BCM
23
Bridgeway Capital Management
Texas
$395K -$173K -20,000 -23%
Goldman Sachs
24
Goldman Sachs
New York
$379K +$461K +53,354 +447%
CSS
25
Cubist Systematic Strategies
Connecticut
$373K -$102K -11,853 -16%

ICVX Hedge Fund Activity: Q1 2023 in Review

66 of the 6,275 institutional investors tracked by Wall St. Rank reported a position in Icosavax, Inc. Common Stock (ICVX) for Q1 2023, worth a combined $195M — down 25% from $258M a quarter earlier.

Buyers outnumbered sellers: 12 funds opened new ICVX positions and 11 closed out — a net gain of 1 holder — while 20 added to existing stakes and 18 trimmed.

The largest buyer was Fidelity Investments, adding an estimated $9.66M. The largest seller was Invesco, exiting entirely with an estimated $3.73M sold.

  • 66 institutional investors held Icosavax, Inc. Common Stock (ICVX) as of Q1 2023, up from 65 in Q4 2022.
  • Funds reported $195M of Icosavax, Inc. Common Stock stock for Q1 2023, down 25% quarter-over-quarter.
  • 12 funds opened new Icosavax, Inc. Common Stock positions in Q1 2023 and 11 closed out, a net change of +1 holder.
  • The largest Icosavax, Inc. Common Stock buyer in Q1 2023 was Fidelity Investments, an estimated $9.66M added.
  • The largest Icosavax, Inc. Common Stock seller in Q1 2023 was Invesco, an estimated $3.73M sold.

Based on aggregated 13F filings for Q1 2023.